Brokerages Set Skye Bioscience, Inc. (NASDAQ:SKYE) Price Target at $16.60
Skye Bioscience, Inc. (NASDAQ:SKYE – Get Free Report) has earned a consensus rating of “Buy” from the six analysts that are currently covering the firm, Marketbeat reports. Six analysts have rated the stock with a buy recommendation. The average 12 month target price among brokerages that have covered the stock in the last year is […]
